{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:27Z","timestamp":1793916507261,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471306"],"award-info":[{"award-number":["82471306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023ZD0504800"],"award-info":[{"award-number":["2023ZD0504800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023ZD0504804"],"award-info":[{"award-number":["2023ZD0504804"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12\\u20132\\u20130012"],"award-info":[{"award-number":["W81XWH-12\\u20132\\u20130012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016101","name":"Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009804","name":"Northern California Institute for Research and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014041","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tjpad.2025.100449","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:01:25Z","timestamp":1767229285000},"page":"100449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Associations of plasma biomarkers with longitudinal co-pathologies in Alzheimer\u2019s disease and cerebral small vessel disease comorbidity"],"prefix":"10.1016","volume":"13","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2388-5967","authenticated-orcid":false,"given":"Xinyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangwei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-2605","authenticated-orcid":false,"given":"Yuhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.tjpad.2025.100449_bib0001","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1212\/WNL.0000000000207739","article-title":"The Brain Health Imperative in the 21st Century-A Call to Action: the AAN Brain Health Platform and Position Statement","volume":"101","author":"Rost","year":"2023","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100449_bib0002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41380-018-0098-1","article-title":"Brain age and other bodily 'ages': implications for neuropsychiatry","volume":"24","author":"Cole","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100449_bib0004","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1152\/physrev.00028.2024","article-title":"The pathogenesis of cerebral small vessel disease and vascular cognitive impairment","volume":"105","author":"Markus","year":"2025","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1590\/1980-57642016dn11-040005","article-title":"Mixed dementia: a review of the evidence","volume":"11","author":"Custodio","year":"2017","journal-title":"Dement Neuropsychol"},{"issue":"6450","key":"10.1016\/j.tjpad.2025.100449_bib0006","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.aay2720","article-title":"The vascular side of Alzheimer's disease","volume":"365","author":"Liesz","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2025.100449_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106845","article-title":"Towards a better diagnosis and treatment of dementia: identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia","volume":"208","author":"Vollhardt","year":"2025","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.tjpad.2025.100449_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101612","article-title":"Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: past, present and future","volume":"77","author":"Gouveia","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100449_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213438","article-title":"Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases","volume":"104","author":"Sanchez","year":"2025","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100449_bib0010","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1002\/alz.14056","article-title":"Potential role of blood pressure variability and plasma neurofilament light in the mechanism of comorbidity between Alzheimer's disease and cerebral small vessel disease","volume":"20","author":"Li","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100449_bib0011","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213706","article-title":"Olfaction and Plasma Biomarkers of Alzheimer Disease and Neurodegeneration in the Atherosclerosis Risk in Communities Study","volume":"104","author":"Shrestha","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100449_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-025-03021-0","article-title":"Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer s disease","author":"Mengel","year":"2025","journal-title":"Mol Psychiatry"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100449_bib0013","first-page":"233","article-title":"Neurofilament light chain induces neuroinflammation","volume":"21","author":"Kiani","year":"2025","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0014","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13024-025-00846-9","article-title":"Cautions on utilizing plasma GFAP level as a biomarker for reactive astrocytes in neurodegenerative diseases","volume":"20","author":"Youn","year":"2025","journal-title":"Mol Neurodegener"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100449_bib0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma Phosphorylated Tau 217 and Abeta42\/40 to Predict Early Brain Abeta Accumulation in People Without Cognitive Impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100449_bib0016","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0017","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1038\/s41467-025-56756-3","article-title":"Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort","volume":"16","author":"Santos","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11357-023-00888-1","article-title":"Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study","volume":"46","author":"van Gennip","year":"2024","journal-title":"Geroscience"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2018.3122","article-title":"Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: a Systematic Review and Meta-analysis","volume":"76","author":"Debette","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/alz.12406","article-title":"Detection of Alzheimer's disease amyloid beta 1-42, p-tau, and t-tau assays","volume":"18","author":"van Harten","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0021","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.25373","article-title":"Reduced brain amyloid burden in elderly patients with narcolepsy type 1","volume":"85","author":"Gabelle","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0022","doi-asserted-by":"crossref","first-page":"894","DOI":"10.18632\/aging.102662","article-title":"Predicting Fazekas scores from automatic segmentations of white matter signal abnormalities","volume":"12","author":"Cedres","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0023","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100449_bib0024","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"De Meyer","year":"2010","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100449_bib0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1001\/archneurol.2011.150","article-title":"Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease","volume":"68","author":"Fleisher","year":"2011","journal-title":"Arch Neurol"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100449_bib0026","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100449_bib0027","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213836","article-title":"Association of Enlarged Perivascular Spaces With Early Serum and Neuroimaging Biomarkers of Alzheimer Disease Pathology","volume":"105","author":"Ong","year":"2025","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0028","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: a cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100449_bib0029","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100449_bib0030","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1002\/alz.13393","article-title":"Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals","volume":"19","author":"Ferreira","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41398-024-03220-3","article-title":"Associations of plasma biomarkers with cerebral perfusion and structure in Alzheimer's disease","volume":"15","author":"He","year":"2025","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0032","article-title":"Clinical and neuropathological associations of plasma Abeta(42)\/Abeta(40), p-tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders","volume":"17","author":"Rajbanshi","year":"2025","journal-title":"Alzheimers Dement (Amst)"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100449_bib0033","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/jamaneurol.2021.2293","article-title":"Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes","volume":"78","author":"Mielke","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100449_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100300","article-title":"The role of Tau, amyloid-beta and neuroinflammation in the association between cognition and white matter hyperintensities in a southeast Asian cohort","author":"Sandhu","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032134","article-title":"Plasma Markers of Alzheimer's Disease Pathology, Neuronal Injury, and Astrocytic Activation and MRI Load of Vascular Pathology and Neurodegeneration: the SMART-MR Study","volume":"13","author":"Twait","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100449_bib0036","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/alz.12447","article-title":"Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease","volume":"18","author":"Chatterjee","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100449_bib0037","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0038","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16226","article-title":"The GFAP proteoform puzzle: how to advance GFAP as a fluid biomarker in neurological diseases","volume":"169","author":"Gogishvili","year":"2025","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100449_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70333","article-title":"Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","article-title":"Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults","volume":"146","author":"Yu","year":"2023","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0041","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JAD-220158","article-title":"Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds","volume":"87","author":"McCarter","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100449_bib0042","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/STROKEAHA.123.046379","article-title":"Diagnostic Accuracy of Posterior\/Anterior Periventricular WMH Ratio to Differentiate CAA From Hypertensive Arteriopathy","volume":"55","author":"Deasy","year":"2024","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0043","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.tjpad.2025.100449_bib0044","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-beta pathology in preclinical Alzheimer's disease","volume":"28","author":"Mila-Aloma","year":"2022","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100449_bib0045","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100449_bib0046","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100449_bib0047","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100449_bib0048","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jamaneurol.2023.3618","article-title":"Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease","volume":"80","author":"Shirzadi","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0049","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/s41467-023-38878-8","article-title":"Evidence against a temporal association between cerebrovascular disease and Alzheimer's disease imaging biomarkers","volume":"14","author":"Cogswell","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100449_bib0050","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1002\/alz.14126","article-title":"White matter hyperintensity on MRI and plasma Abeta42\/40 ratio additively increase the risk of cognitive impairment in hypertensive adults","volume":"20","author":"de Havenon","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100449_bib0051","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jalz.2017.01.026","article-title":"Associations between amyloid beta and white matter hyperintensities: a systematic review","volume":"13","author":"Roseborough","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100449_bib0052","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209801","article-title":"Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia","volume":"103","author":"Lorenzini","year":"2024","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100449_bib0053","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13195-024-01423-w","article-title":"Amyloid beta oligomer induces cerebral vasculopathy via pericyte-mediated endothelial dysfunction","volume":"16","author":"Chen","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100449_bib0054","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/glia.24634","article-title":"Glial 'omics in ischemia: acute stroke and chronic cerebral small vessel disease","volume":"73","author":"McDonough","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.tjpad.2025.100449_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106663","article-title":"Brain incoming call from glia during neuroinflammation: roles of extracellular vesicles","volume":"201","author":"D'Egidio","year":"2024","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100449_bib0056","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.tjpad.2025.100449_bib0057","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimers Dement"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:26:16Z","timestamp":1776198376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2274580725003905"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100449","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of plasma biomarkers with longitudinal co-pathologies in Alzheimer\u2019s disease and cerebral small vessel disease comorbidity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100449"}}